Latest Market News

Energy Action Ltd reported a 17% revenue increase to $2.89 million in Q1 FY26, driven by strong contract renewals and new business wins, alongside strategic investments in AI-enhanced technology to expand emissions management services.

Acrux Limited reports robust revenue growth in Q1 FY26, driven by strong profit share income from recently launched topical pharmaceuticals and a significant R&D tax rebate repayment.

European Metals Holdings has advanced its Cinovec Lithium Project with a new preliminary mining permit and secured funding to complete its Definitive Feasibility Study, reinforcing its position in Europe's critical raw materials landscape.

Northern Minerals Limited reported a net operating cash outflow of AUD 6.61 million for Q3 2025, ending the quarter with AUD 17.48 million in cash and equivalents and a solid financing facility.

Northern Minerals reports a robust Definitive Feasibility Study and secures conditional funding interest, positioning Browns Range as a critical supplier of heavy rare earths by 2028.

Basin Energy has acquired NeoDys Limited, gaining a substantial uranium and rare earth exploration package in Queensland, and launched a $1.25 million capital raise to fund maiden drilling in late 2025.

Spenda Limited reported a record $204 million in payment volumes for Q1 FY26 alongside a strategic cost reduction of 21% annualised. The quarter also saw a significant leadership change with the resignation of its Managing Director.

KALiNA Power advances its Alberta AI data centre power projects with a significant CAD 18 million transfer of assigned megawatts and engages bankers to fund development capital.

Regener8 Resources has completed Phase 1 soil sampling at its North Achilles project using advanced Ultrafine™ geochemical techniques, positioning itself to leverage strong metal prices and nearby discoveries in the Cobar Basin.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.

Galilee Energy reported steady cash reserves and ongoing reservoir pressure monitoring at its Glenaras Gas Project, while exploring new funding and growth opportunities.